Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Corona Remedies Ltd.
Swot
Corona Remedies Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Corona Remedies Ltd. has 19 Strengths, 4 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(19)
Weakness
(4)
Opportunity
(0)
Threats
(1)
Others
(0)
Results declared today, with net profit and revenue growth YoY and QoQ
Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
Results in the last two days with YoY and QoQ Net Profit Growth
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Companies with Zero Promoter Pledge
Near 52 Week High
Stock gained more than 20% in one month
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Companies with growing costs YoY for long term projects
Increasing Trend in Non-Core Income
Top Losers
Near 52 Week Low
Companies with high market cap, lower public shareholding